about
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data.An international comparison of costs of end-of-life care for advanced lung cancer patients using health administrative data.Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope.A guide to economic evaluation: methods for cost-effectiveness analysis of person-level data.Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial.Is ambulatory monitoring for "community-acquired" syncope economically attractive? A cost-effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring.Pattern of antidepressant use and duration of depression-related absence from work.Improving efficiency and value in palliative care with net benefit regression: an introduction to a simple method for cost-effectiveness analysis with person-level data.An interprofessional nurse-led mental health promotion intervention for older home care clients with depressive symptoms.Increased risk of miscarriage among women experiencing physical or sexual intimate partner violence during pregnancy in Guatemala City, Guatemala: cross-sectional studyReducing depression in older home care clients: design of a prospective study of a nurse-led interprofessional mental health promotion intervention.Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis.Meaningful patient representation informing Canada's cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug ReviewPopulation-based utilization of radiation therapy by a Canadian breast cancer cohortSafety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis.Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial.Expanding Paramedicine in the Community (EPIC): study protocol for a randomized controlled trial.End-of-life care for lung cancer patients in the United States and Ontario.DO IT Trial: vitamin D Outcomes and Interventions in Toddlers - a TARGet Kids! randomized controlled trial.Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment.Economic evaluation of hormonal therapies for postmenopausal women with estrogen receptor-positive early breast cancer in CanadaA systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound typesHealth status, quality of life, residential stability, substance use, and health care utilization among adults applying to a supportive housing program.The effectiveness of an integrated collaborative care model vs. a shifted outpatient collaborative care model on community functioning, residential stability, and health service use among homeless adults with mental illness: a quasi-experimental stuBarriers to Mental Health Service Use Among Workers With Depression and Work Productivity.A Time-Trend Economic Analysis of Cancer Drug Trials.The impact of stratifying by family history in colorectal cancer screening programs.A population-based study of the epidemiology of pancreatic cancer: a brief reportPopulation-based home care services in breast cancer: utilization and costs.Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: the Pan-Canadian Oncology Drug ReviewPathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference.Overcoming obstacles in accessing unfunded oral chemotherapy: physician experience and challenges.Pathogen inactivation: making decisions about new technologies. Report of a consensus conference.Technology-Enabled Remote Monitoring and Self-Management - Vision for Patient Empowerment Following Cardiac and Vascular Surgery: User Testing and Randomized Controlled Trial Protocol.Cost-effectiveness analysis: what it really means for transfusion medicine decision making.Enhancing Self-Efficacy for Help-Seeking Among Transition-Aged Youth in Postsecondary Settings With Mental Health and/or Substance Use Concerns, Using Crowd-Sourced Online and Mobile Technologies: The Thought Spot Protocol.How can diagnostic assessment programs be implemented to enhance inter-professional collaborative care for cancer?Fixed and flexible formularies as cost-control mechanisms.A review of economic evaluations of genetic testing services and interventions (2004-2009).Is knowledge translation adequate? A quality assurance study of staging investigations in early stage breast cancer patients.
P50
Q30928428-DD7227DC-F7F7-48CC-A042-0B309A529985Q30991092-91E7930C-4293-42EC-8CEC-581CEFE9EEA5Q31043509-154E2824-23F3-4B30-8F70-C4E4CCCD0540Q31088958-0C3F23B0-48F5-4B51-B04B-96F60169E6E7Q33149226-DFFDC3A7-917B-4BC7-837C-2C46E18B8DE1Q33153304-EEC50FCE-511B-44AB-BCE0-2D566A7C47EBQ33339443-DDC2C5EF-4CB6-4EB7-9F9B-9C9D7651EFEEQ33483870-7A9A9557-8857-42C3-8211-C2C6055E5433Q33606349-1A147027-6497-4B75-93E8-B9750657F17CQ33953021-0A22A425-6827-4DE6-B2D5-E95CBF6ABA3DQ34002938-87F119C4-342B-4018-9167-C2C753E9890CQ34105982-C1B627E9-3769-4AD4-872C-903BCE088742Q34305909-4B990D27-372D-4D3A-8681-F6D5BAE81D2BQ34305940-ECE6AD53-7E4C-4343-B40F-D4C2FF720844Q34349437-F7576E79-F7D6-429D-8C62-A56E87F78EF3Q34477982-DC0F0A26-261F-4E71-9661-16502A14DAAFQ34897690-880EFF12-30FB-43A1-87AC-39E30FC1251CQ35047094-96A233DE-6136-4E2D-A3FA-3840AA0BBD70Q35088946-9D09467F-15F9-4ACC-AB74-375DAAD4F4A9Q35287159-06891C72-1CFB-4FED-85D1-317D6683CEFEQ35445037-AFAB6C72-23A7-43B8-AB77-E857689590F2Q35519326-AEC8724D-4E52-4833-998A-96C236D44D4FQ35597420-75FFB645-F633-4B14-81BB-141BA338C37FQ35758032-46D367B6-B3DB-40B7-B2C6-F35562D0451FQ35777604-C6ACDD46-85B9-449F-8750-FB6645AC0F04Q35820527-57355F62-40B2-48D1-AEB7-6F98AA74B721Q35925267-01527E85-3963-4B63-A44F-258A25B664DFQ36394629-5D3343AD-7D57-4672-8D99-FE2830AD9BCAQ36416246-5F048497-FD4D-4720-8EB0-C78DD1BB8AF5Q36738521-5322F929-5197-42AD-84E3-ECDC3FF598BCQ36903922-B338FB27-006B-4F23-8213-D669F67983ADQ37008510-23EBA704-0E10-4701-99A8-64B519D8E2B6Q37013124-B3240FC9-B813-4597-BA3B-55EF0E121FCDQ37207761-8A78F139-91A4-405E-AB6F-DFCAB3346FF9Q37341087-EDAD5D0E-ED50-45DA-8CAF-50F5142E2F7FQ37423815-88FA6771-96B7-42F6-A810-36524CF9C019Q37446274-D7A3BCD7-8043-44A3-A836-0A42FAC36D1AQ37609232-80585122-B127-4D20-B24E-7A85862FB2A3Q37832922-02C919BB-B90B-43A2-9641-976FD45AD7F7Q37938820-2584A9AC-71BB-431B-8FBC-06EA13E925D1
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jeffrey S. Hoch
@ast
Jeffrey S. Hoch
@en
Jeffrey S. Hoch
@es
Jeffrey S. Hoch
@nl
Jeffrey S. Hoch
@sl
type
label
Jeffrey S. Hoch
@ast
Jeffrey S. Hoch
@en
Jeffrey S. Hoch
@es
Jeffrey S. Hoch
@nl
Jeffrey S. Hoch
@sl
prefLabel
Jeffrey S. Hoch
@ast
Jeffrey S. Hoch
@en
Jeffrey S. Hoch
@es
Jeffrey S. Hoch
@nl
Jeffrey S. Hoch
@sl
P1053
O-3406-2017
P106
P1153
7103032035
P21
P31
P3829
P496
0000-0002-4880-4281